Compositions and methods for treating cancer
US8609631B2 · kind B2 · utility
3Cited by
28References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2012 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Oct 31, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.